• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    35.15 Down 0.85(2.36%) Mar 3, 4:00PM EST
    |Pre-Market : 35.14 Down 0.01 (0.03%) 5:05PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:36.00
    Open:35.87
    Bid:30.75 x 400
    Ask:64.86 x 100
    1y Target Est:43.20
    Beta:2.4
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:34.60 - 36.00
    52wk Range:30.05 - 55.46
    Volume:1,503,319
    Avg Vol (3m):1,383,400
    Market Cap:4.37B
    P/E (ttm):N/A
    EPS (ttm):-0.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 2.36%4.37B
    IMGNDown 4.44%649.25M
    PFEDown 0.60%211.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.71
    Quarterly EPS Est (Mar-15) :-0.19
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-1.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback